Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept for prevention of macular edema in diabetic retinopathy patients undergoing cataract surgery
NCT01988246Phase 2Completed
- Sponsor
- Rishi Singh
- Start
- Dec 2013
- Primary completion
- Apr 2018
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of aflibercept in diabetic retinopathy (DR), sponsored by Rishi Singh. Started Dec 2013; status: completed.
02
Drugs
aflibercept
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT01988246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01988246.